Nikkei projected that the GOJ is set to close a deal in the near future with UK pharmaceutical company AstraZeneca on the provision of coronavirus vaccines for at least 50 million people in Japan. A clinical test of the vaccine currently under development with the University of Oxford is reportedly expected to start in Japan shortly.
Japan likely to seal deal with UK firm on provision of COVID-19 vaccines
- August 6, 2020
- , Nikkei
- JMH Summary
- COVID-19
